Table 5.
Propolis Source | Study Design | Dose | Measured Outcome | References |
---|---|---|---|---|
Portuguese propolis, Bornes and Fundão regions | RCC model | Hemolytic protection IC50, Bornes = 6.3 ± 0.7 μg/mL Fundão = 10.4 ± 2.7 μg/mL Anticancer activity IC50 Bornes = 56.5 ± 16.7 μg/mL Fundão = 56.1 ± 20.9 μg/mL |
|
[71] |
CAPE | MCF-7 cell line | IC50 = 10 μg/mL |
|
[72] |
Brazilian red propolis, CAPE |
MCF-7 tumor cells and human fibroblasts | Propolis = 0.1–20 μg/mL CAPE = 0.1–2 μM |
|
[73] |
Chinese propolis ethanolic extract |
MDA- MB-231, MCF -7 tumor cell line |
25, 50, 100, 200 μg/mL |
|
[74] |
Chinese propolis ethanolic extract, CAPE |
MDA- MB-231 tumor cell line | Propolis extract = 25 μg/mL (low dose), 50 μg/mL (middle dose) and 100 μg/mL (high dose) CAPE = 25 μg/mL |
|
[75] |
Cuban red propolis | MDA- MB-231 tumor cell line | IC50 = 67.3 μg/mL |
|
[76] |
Chinese poplar propolis | MDA- MB-231 tumor cell line | Low dose = 25 μg/mL, middle = 50 μg/mL and high = 100 μg/mL |
|
[77] |